Cytomegalovirus DNAemia developed in 24 ( 43 % ) of 59 patients in the valacyclovir group and 18 ( 31 % ) of 60 patients in the valganciclovir group ( adjusted hazard ratio , 1.35 ; 95 % confidence interval , 0.71 to 2.54 ; P = 0.36 ) .